Deals
Teva Has Appetite for ‘Game-Changing Deals,’ CFO Desheh Says
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd. Chief Financial Officer Eyal Desheh said the world’s largest generic drugmaker is open for deals as the pace of industry consolidation quickens.
“We do have an appetite for game-changing deals that will create value by doing the transaction and we’re willing to pursue them,” Desheh said yesterday at a Cowen & Company health-care conference, when asked about the “fragmented” market of neurology companies.